Antithrombin III and heparin. 1980

V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
May 1988, Zhonghua fu chan ke za zhi,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
March 1978, Lancet (London, England),
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
April 1978, Lancet (London, England),
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
April 1987, Rinsho byori. The Japanese journal of clinical pathology,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
May 1978, British medical bulletin,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
March 1986, The Journal of biological chemistry,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
February 1980, Lancet (London, England),
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
January 1974, Haematologia,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
July 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
V V Kakkar, and P G Bentley, and M F Scully, and I R MacGregor, and N A Jones, and P J Webb
February 1985, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!